Novo Nordisk A/S (LON:0TDD)
London flag London · Delayed Price · Currency is GBP · Price in USD
50.59
+0.62 (1.23%)
At close: Aug 13, 2025

Novo Nordisk Revenue

Novo Nordisk had revenue of 76.86B DKK in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to 311.94B, up 20.90% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
311.94B DKK
Revenue Growth
+20.90%
P/S Ratio
4.67
Revenue / Employee
4.03M DKK
Employees
77,349
Market Cap
167.56B GBP

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 41.24B
HSBC Holdings 41.03B
Shell 198.54B
Unilever 51.24B
British American Tobacco p.l.c. 25.60B
Rolls-Royce Holdings 19.54B
Rio Tinto Group 39.22B
BP p.l.c. 134.89B
Revenue Rankings